Bavarian Nordic A/S, a worldwide vaccine firm dedicated to enhancing health and saving lives via innovative vaccines, revealed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...
Onco-Innovations Limited, a Canadian firm focused on cancer research and treatment, specializing in oncology, has shared details about its licensed technology involving a novel class of PNKP (Polynucleotide Kinase 3'-Phosphatase) inhibitors...
Telix Pharmaceuticals Limited, a biopharmaceutical firm dedicated to the advancement and marketing of therapeutic and diagnostic radiopharmaceuticals alongside related medical technologies, declared that it has finalized the acquisition from the...
Sudarshan Pharma Industries revealed the authorization of Rs 188 Cr in capital raising via 4.3 Cr convertible warrants. The firm acknowledged the contract established between the Monitoring agency and the enterprise on January 29, 2025, and...
The Union Budget 2025 has proposed a 9.78 per cent rise in funding for healthcare for the fiscal year 2025-26, amounting to Rs. 99,858.56 crore in contrast to Rs. The ministry of health and family welfare states that the amount will be 90,958.63...
Renalys Pharma, Inc., a privately owned late-stage clinical biopharmaceutical firm located in Japan, declared that it has finalized patient enrollment and achieved the target case number for its registrational phase III clinical trial of...
Houston-based March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, announced that the US Food and Drug Administration (FDA) granted orphan drug designation to MB-105...
Quantum-Si Incorporated, the protein sequencing firm, and IDEX Health & Science, LLC, announced a collaboration to develop and manufacture the optics module for Quantum-Si's innovative proteomics platform, Proteus. IDEX Health & Science, LLC...
After a successful edition of the maiden award ceremony in 2024, Eminence is thrilled to announce the Pharma Quality Excellence Awards 2025, taking place on April 25th, 2025, in conjunction with the 5th Annual Pharma GMP and Quality Management 2025
The pharmaceutical industry is undergoing rapid transformation, with an increasing focus on quality, compliance, and innovation in manufacturing processes. In this context, Eminence Business Media has announced 5th Annual Pharma GMP and Quality Manag
, CDSCO.jpg)
